Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 2/20 | 0.50 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.45 |
| ▸ | CREBBP | Q92793 | 9/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 5/20 | 0.40 |
| ▸ | GRM5 | P41594 | 1/20 | 0.39 |
| ▸ | NAMPT | P43490 | 1/20 | 0.38 |
| ▸ | EP300 | Q09472 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14861328 | 0.87 | PDK2 (0.45) | NOTUMPDK2NAMPTTDP1ALDH1A1 | |
| SCHEMBL26542931 | 0.85 | NOTUM (0.48) | NOTUMPDK2CREBBPBRD4NAMPT | |
| SCHEMBL16217165 | 0.80 | MAPT (0.54) | PDK2NAMPT | |
| SCHEMBL12489993 | 0.75 | MAOA (0.45) | — | |
| SCHEMBL28877856 | 0.75 | HDAC1 (0.42) | NOTUMPDK2NAMPTALDH1A1 | |
| SCHEMBL25111568 | 0.74 | DPP8 (0.38) | PDK2 | |
| SCHEMBL22494809 | 0.74 | PDK2 (0.47) | NOTUMPDK2CREBBPENPP2BRD4 | |
| SCHEMBL31348202 | 0.73 | HDAC1 (0.44) | NOTUMPDK2NAMPTALDH1A1 | |
| SCHEMBL25217122 | 0.73 | NOTUM (0.53) | NOTUMCREBBPENPP2BRD4GRM5 | |
| SCHEMBL7011414 | 0.73 | NOTUM (0.53) | NOTUMCREBBPENPP2BRD4GRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023036140-A1 | 3CLPRO PROTEASE INHIBITOR | 上海齐鲁制药研究中心有限公司 | 2023-03-16 | — | — | WO | disclosed |